SCHEMBL18862875

SCHEMBL18862875

COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC=O

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 16/20 0.75
▸ ERBB2 P04626 4/20 0.75
▸ KDR P35968 2/20 0.75
▸ PDGFRB P09619 2/20 0.75
▸ FBP1 P09467 2/20 0.75
▸ AURKA O14965 1/20 0.75
▸ INSR P06213 1/20 0.75
▸ FLT4 P35916 1/20 0.75
▸ CLK1 P49759 1/20 0.75
▸ EPHB4 P54760 1/20 0.75
▸ TEK Q02763 1/20 0.75
▸ AURKB Q96GD4 1/20 0.75
▸ ERBB3 P21860 1/20 0.72
▸ DUS2 Q9NX74 1/20 0.72
▸ ERBB4 Q15303 2/20 0.70
▸ HDAC3 O15379 2/20 0.65
▸ HDAC4 P56524 2/20 0.65
▸ HDAC1 Q13547 2/20 0.65
▸ HDAC7 Q8WUI4 2/20 0.65
▸ HDAC2 Q92769 2/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18632967 0.90 FBP1 (0.76) EGFRERBB2KDRPDGFRBFBP1
SCHEMBL21761246 0.89 EGFR (0.58) EGFRERBB2KDRPDGFRBFBP1
SCHEMBL22519385 0.88 EGFR (0.81) EGFRERBB2KDRPDGFRBFBP1
SCHEMBL19125553 0.87 EGFR (0.63) EGFRERBB2KDRPDGFRBFBP1
SCHEMBL21761244 0.87 EGFR (0.63) EGFRERBB2KDRPDGFRBFBP1
SCHEMBL19026693 0.86 EGFR (0.74) EGFRERBB2KDRPDGFRBFBP1
SCHEMBL2099106 0.86 EGFR (1.00) EGFRERBB2KDRPDGFRBFBP1
SCHEMBL30505605 0.86 EGFR (1.00) EGFRERBB2KDRPDGFRBFBP1
SCHEMBL4445788 0.86 EGFR (0.78) EGFRERBB2KDRPDGFRBFBP1
SCHEMBL30474633 0.85 EGFR (0.81) EGFRERBB2KDRPDGFRBFBP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2716633-B1 QUINAZOLINE DERIVATIVE AS TYROSINE-KINASE INHIBITOR, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF XUANZHU PHARMA CO LTD (CN) 2017-05-17 — — EP disclosed
Send feedback